These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 31138497)

  • 21. [Mycobacterial lung disease in patients with cystic fibrosis--report of three cases].
    Wyrostkiewicz D; Skorupa W; Jakubowska L; Zabost A; Kuś J
    Pneumonol Alergol Pol; 2014; 82(6):561-7. PubMed ID: 25339567
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antimycobacterial activity of nonantibiotics associated with the polypharmacy of cystic fibrosis (CF) against mycobacterium abscessus.
    Kirkwood ZI; Millar BC; Downey DG; Moore JE
    Int J Mycobacteriol; 2018; 7(4):358-360. PubMed ID: 30531035
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomized Trial of Liposomal Amikacin for Inhalation in Nontuberculous Mycobacterial Lung Disease.
    Olivier KN; Griffith DE; Eagle G; McGinnis JP; Micioni L; Liu K; Daley CL; Winthrop KL; Ruoss S; Addrizzo-Harris DJ; Flume PA; Dorgan D; Salathe M; Brown-Elliott BA; Gupta R; Wallace RJ
    Am J Respir Crit Care Med; 2017 Mar; 195(6):814-823. PubMed ID: 27748623
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A shorter treatment duration may be sufficient for patients with Mycobacterium massiliense lung disease than with Mycobacterium abscessus lung disease.
    Lyu J; Kim BJ; Kim BJ; Song JW; Choi CM; Oh YM; Lee SD; Kim WS; Kim DS; Shim TS
    Respir Med; 2014 Nov; 108(11):1706-12. PubMed ID: 25245792
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nontuberculous mycobacterial infections in cystic fibrosis.
    Martiniano SL; Nick JA
    Clin Chest Med; 2015 Mar; 36(1):101-15. PubMed ID: 25676523
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microbiological profile, preclinical pharmacokinetics and efficacy of CRS0393, a novel antimycobacterial agent targeting MmpL3.
    Ochsner UA; De Groote MA; Jarvis TC; Liu H; Youmans T; Hoang T; Ribble W; Day J; Li W; Pearce C; Walz A; Panthi CM; Rimal B; Stevens CM; Zgurskaya HI; Jackson M; Ordway D; Gonzalez-Juarrero M; Sun X; Lamichhane G; Mason C
    Tuberculosis (Edinb); 2023 Jan; 138():102288. PubMed ID: 36470124
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparing Mycobacterium massiliense and Mycobacterium abscessus lung infections in cystic fibrosis patients.
    Roux AL; Catherinot E; Soismier N; Heym B; Bellis G; Lemonnier L; Chiron R; Fauroux B; Le Bourgeois M; Munck A; Pin I; Sermet I; Gutierrez C; Véziris N; Jarlier V; Cambau E; Herrmann JL; Guillemot D; Gaillard JL;
    J Cyst Fibros; 2015 Jan; 14(1):63-9. PubMed ID: 25085077
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Challenging scenarios in nontuberculous mycobacterial infection in cystic fibrosis.
    Martiniano SL; Esther CR; Haworth CS; Kasperbauer SH; Zemanick ET; Caverly LJ
    Pediatr Pulmonol; 2020 Feb; 55(2):521-525. PubMed ID: 31821718
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In Vitro Efficacy of Free and Nanoparticle Formulations of Gallium(III) meso-Tetraphenylporphyrine against Mycobacterium avium and Mycobacterium abscessus and Gallium Biodistribution in Mice.
    Choi SR; Britigan BE; Switzer B; Hoke T; Moran D; Narayanasamy P
    Mol Pharm; 2018 Mar; 15(3):1215-1225. PubMed ID: 29421865
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis.
    Waters V; Ratjen F
    Cochrane Database Syst Rev; 2014 Dec; (12):CD010004. PubMed ID: 25470304
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis.
    Waters V; Ratjen F
    Cochrane Database Syst Rev; 2012 Dec; 12():CD010004. PubMed ID: 23235684
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis.
    Waters V; Ratjen F
    Cochrane Database Syst Rev; 2016 Dec; 12(12):CD010004. PubMed ID: 28000919
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhaled amikacin for treatment of refractory pulmonary nontuberculous mycobacterial disease.
    Olivier KN; Shaw PA; Glaser TS; Bhattacharyya D; Fleshner M; Brewer CC; Zalewski CK; Folio LR; Siegelman JR; Shallom S; Park IK; Sampaio EP; Zelazny AM; Holland SM; Prevots DR
    Ann Am Thorac Soc; 2014 Jan; 11(1):30-5. PubMed ID: 24460437
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibiotic treatment for nontuberculous mycobacterial lung disease.
    Kang YA; Koh WJ
    Expert Rev Respir Med; 2016; 10(5):557-68. PubMed ID: 26967761
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nontuberculous mycobacteria in cystic fibrosis: Updates and the path forward.
    Martiniano SL; Davidson RM; Nick JA
    Pediatr Pulmonol; 2017 Nov; 52(S48):S29-S36. PubMed ID: 28881094
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increasing nontuberculous mycobacteria infection in cystic fibrosis.
    Bar-On O; Mussaffi H; Mei-Zahav M; Prais D; Steuer G; Stafler P; Hananya S; Blau H
    J Cyst Fibros; 2015 Jan; 14(1):53-62. PubMed ID: 24917112
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro evaluation of a new drug combination against clinical isolates belonging to the Mycobacterium abscessus complex.
    Singh S; Bouzinbi N; Chaturvedi V; Godreuil S; Kremer L
    Clin Microbiol Infect; 2014 Dec; 20(12):O1124-7. PubMed ID: 25185732
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nontuberculous mycobacteria in the setting of cystic fibrosis.
    Ebert DL; Olivier KN
    Clin Chest Med; 2002 Sep; 23(3):655-63. PubMed ID: 12371001
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In Vitro Activity and Clinical Outcomes of Clofazimine for Nontuberculous Mycobacteria Pulmonary Disease.
    Kim DH; Kim BG; Kim SY; Huh HJ; Lee NY; Koh WJ; Kim H; Kwon OJ; Jhun BW
    J Clin Med; 2021 Oct; 10(19):. PubMed ID: 34640599
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduced risk of nontuberculous mycobacteria in cystic fibrosis adults receiving long-term azithromycin.
    Coolen N; Morand P; Martin C; Hubert D; Kanaan R; Chapron J; Honoré I; Dusser D; Audureau E; Veziris N; Burgel PR
    J Cyst Fibros; 2015 Sep; 14(5):594-9. PubMed ID: 25735458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.